165 related articles for article (PubMed ID: 27638853)
1. Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD.
Kepecs DM; Yuen DA; Zhang Y; Thai K; Connelly KA; Gilbert RE
J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27638853
[TBL] [Abstract][Full Text] [Related]
2. Repeated treatment with bone marrow cell secretory products maintains long-term renoprotection in experimental chronic kidney disease: a placebo-controlled trial.
Yuen DA; Kepecs DM; Zhang Y; Advani S; Thai K; Connelly KA; Gilbert RE
Can J Kidney Health Dis; 2015; 2():44. PubMed ID: 26568839
[TBL] [Abstract][Full Text] [Related]
3. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
4. Late intervention in the remnant kidney model attenuates proteinuria but not glomerular filtration rate decline.
Veitch MR; Thai K; Zhang Y; Desjardins JF; Kabir G; Connelly KA; Gilbert RE
Nephrology (Carlton); 2021 Mar; 26(3):270-279. PubMed ID: 33179827
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system blockade alone or combined with ET
Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
[TBL] [Abstract][Full Text] [Related]
6. Combination of ACE inhibitor with nicorandil provides further protection in chronic kidney disease.
Shiraishi T; Tamura Y; Taniguchi K; Higaki M; Ueda S; Shima T; Nagura M; Nakagawa T; Johnson RJ; Uchida S
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1313-22. PubMed ID: 25320353
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
[TBL] [Abstract][Full Text] [Related]
8. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
Nakamura T; Fujiwara N; Kawagoe Y; Sugaya T; Ueda Y; Koide H
Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070
[TBL] [Abstract][Full Text] [Related]
9. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
[TBL] [Abstract][Full Text] [Related]
10. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
Xu XX; Zhang W; Zhang P; Qi XM; Wu YG; Shen JJ
Phytomedicine; 2013 Jul; 20(10):820-7. PubMed ID: 23664882
[TBL] [Abstract][Full Text] [Related]
11. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats.
Wang JL; Cheng HF; Shappell S; Harris RC
Kidney Int; 2000 Jun; 57(6):2334-42. PubMed ID: 10844603
[TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
13. Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.
Čertíková Chábová V; Kujal P; Škaroupková P; Varňourková Z; Vacková Š; Husková Z; Kikerlová S; Sadowski J; Kompanowska-Jezierska E; Baranowska I; Hwang SH; Hammock BD; Imig JD; Tesař V; Červenka L
Kidney Blood Press Res; 2018; 43(2):329-349. PubMed ID: 29529602
[TBL] [Abstract][Full Text] [Related]
14. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
15. Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.
Ismail B; deKemp RA; Croteau E; Hadizad T; Burns KD; Beanlands RS; DaSilva JN
PLoS One; 2017; 12(5):e0177451. PubMed ID: 28542215
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
17. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation.
Ots M; Mackenzie HS; Troy JL; Rennke HG; Brenner BM
J Am Soc Nephrol; 1998 Feb; 9(2):224-30. PubMed ID: 9527398
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
Tylicki L; Rutkowski P; Renke M; Rutkowski B
Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
[TBL] [Abstract][Full Text] [Related]
20. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.
Benigni A; Zoja C; Zatelli C; Corna D; Longaretti L; Rottoli D; Maggioni P; Todeschini M; Noris M; Remuzzi G
Kidney Int; 2004 Nov; 66(5):1959-65. PubMed ID: 15496167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
